PARAMETRIC PORTFOLIO ASSOCIATES LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,491,000
+224.1%
45,505
+160.6%
0.00%
Q4 2021$460,000
-91.2%
17,462
-66.5%
0.00%
-100.0%
Q3 2021$5,251,000
-39.7%
52,188
-15.1%
0.00%
-40.0%
Q2 2021$8,702,000
+64.3%
61,482
+15.7%
0.01%
+66.7%
Q1 2021$5,298,000
-15.0%
53,136
+5.4%
0.00%
-25.0%
Q4 2020$6,231,000
+213.6%
50,403
+147.1%
0.00%
+300.0%
Q3 2020$1,987,000
-46.4%
20,397
-14.1%
0.00%
-66.7%
Q2 2020$3,706,000
+16.2%
23,751
+7.5%
0.00%0.0%
Q1 2020$3,190,000
-43.6%
22,101
-20.1%
0.00%
-25.0%
Q4 2019$5,656,000
+285.5%
27,665
+51.4%
0.00%
+300.0%
Q3 2019$1,467,000
-51.0%
18,275
-42.4%
0.00%
-50.0%
Q2 2019$2,991,000
+15.2%
31,703
+4.3%
0.00%0.0%
Q1 2019$2,597,000
+122.9%
30,385
+46.3%
0.00%
+100.0%
Q4 2018$1,165,000
-28.1%
20,769
+4.8%
0.00%0.0%
Q3 2018$1,620,00019,8140.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders